IN8bio, Inc.INABNASDAQ
Loading
Operating Cash Flow Growth AcceleratingAccelerating
Percentile Rank93
5Y CAGR+15.9%
Year-over-Year Change
Year-over-year operating cash flow growth rate
5Y CAGR
+15.9%/yr
Long-term compound
Percentile
P93
Near historical high
vs 5Y Ago
2.1x
Strong expansion
Streak
2 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 39.30% |
| Q3 2025 | 10.26% |
| Q2 2025 | -25.78% |
| Q1 2025 | 22.49% |
| Q4 2024 | 34.09% |
| Q3 2024 | -0.33% |
| Q2 2024 | 23.08% |
| Q1 2024 | -63.28% |
| Q4 2023 | 15.11% |
| Q3 2023 | -7.03% |
| Q2 2023 | 28.24% |
| Q1 2023 | 6.42% |
| Q4 2022 | -38.46% |
| Q3 2022 | 2.23% |
| Q2 2022 | -28.80% |
| Q1 2022 | -39.29% |
| Q4 2021 | -51321.84% |
| Q3 2021 | 99.74% |
| Q2 2021 | 1.83% |
| Q1 2021 | -45.33% |
| Q4 2020 | 18.79% |
| Q3 2020 | -127774.77% |
| Q2 2020 | 99.90% |
| Q1 2020 | -116746.65% |
| Q4 2019 | 0.00% |
| Q3 2019 | -37.32% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |